Bifidobacterium animalis subsp. lactis HN019, or B. lactis HN019, is one strain of bifidobacteria. It is sold as an ingredient of supplements, foods and drinks. Trials have given it alone and mixed with other strains or with fiber. Trial amounts are counts of live cells, in colony-forming units (CFU).
Terms and sources
one strain
See the NIH ODS line on how strains are named, in the section below.
an ingredient
Cheng et al., Frontiers in Nutrition, 2021, a review by staff of IFF. The review states that IFF manufactures and markets HN019.
mixed with other strains
Cheng et al., 2021, list both kinds of trials.
colony-forming units (CFU)
Trials listed in an IFF staff review gave 10 million to 300 billion CFU a day. See the NIH ODS lines on labels under Forms.
Bifidobacterium lactis HN019 in the body
HN019 is not a nutrient, and the body has no daily requirement for it. Its trials measure things such as immune cell tests in blood, gut transit time and stool habits.
NIH ODS notes: "Probiotics are identified by their genus, species, and strain designation; some probiotics also receive subspecies names." For HN019, the genus is Bifidobacterium, the species animalis, the subspecies lactis and the strain HN019. Many papers shorten the name to Bifidobacterium lactis HN019. NIH ODS adds: "Probiotic products often contain microbial organisms from the genera Bifidobacterium, Saccharomyces, Streptococcus, Enterococcus, Escherichia, and Bacillus and from the family Lactobacillaceae." NCCIH notes: "The most common are bacteria that belong to groups called Lactobacillus and Bifidobacterium." It adds: "Different types of probiotics may have different effects." Other commercial strains of the same subspecies include BB-12 and DN-173 010.
Terms and sources
NIH ODS notes
NIH Office of Dietary Supplements, fact sheet for health professionals.
Many papers
For example, Waller et al., 2011.
NCCIH notes
National Center for Complementary and Integrative Health, Probiotics: Usefulness and Safety.
BB-12 and DN-173 010
Named in the IFF staff review, Cheng et al., 2021. They are different strains from HN019.
NIH ODS writes: "The International Scientific Association for Probiotics and Prebiotics defines probiotics as ‘live microorganisms that, when administered in adequate amounts, confer a health benefit on the host.’" It adds: "However, not all foods and dietary supplements that are labeled as probiotics have proven health benefits."
Terms and sources
NIH ODS writes
ISAPP consensus statement of 2014, as quoted by NIH ODS.
On safety, NIH ODS notes: "Probiotics are unlikely to cause harm in healthy people, and side effects are usually minor." It adds: "However, the use of probiotics has been linked to a few cases of bacteremia, fungemia, and infections that have resulted in severe illness; most of these cases involved individuals who were severely ill or immunocompromised."
Terms and sources
On safety
The first paragraph of the Safety Considerations section of the NIH ODS fact sheet, in two sentences. The rest of the section describes case reports and hospital data.
bacteremia, fungemia
Bacteria or fungi in the blood (our explanation).
Under its heading on possible harm, NCCIH says: "Probiotics have an extensive history of apparently safe use, particularly in healthy people." It continues: "However, few studies have looked at the safety of probiotics in detail, so there’s a lack of solid information on the frequency and severity of side effects." NCCIH adds: "The risk of harmful effects from probiotics is greater in people with severe illnesses or compromised immune systems." "When probiotics are being considered for high-risk individuals, such as premature infants or seriously ill hospital patients, the potential risks of probiotics should be carefully weighed against their benefits." "Cases of severe or fatal infections have been reported in premature infants who were given probiotics, and the U.S. Food and Drug Administration (FDA) has warned health care providers about this risk." It also lists: "Possible harmful effects of probiotics include infections, production of harmful substances by the probiotic microorganisms, and transfer of antibiotic resistance genes from probiotic microorganisms to other microorganisms in the digestive tract." And: "Some probiotic products have been reported to contain microorganisms other than those listed on the label." "In some instances, these contaminants may pose serious health risks." NCCIH advises: "Don’t use probiotics as a reason to postpone seeing your health care provider about any health problem." It adds: "If you’re considering a probiotic dietary supplement, consult your health care provider first." It continues: "This is especially important if you have health problems." And: "Anyone with a serious underlying health condition should be monitored closely while taking probiotics."
Terms and sources
possible harm
The whole section, in four paragraphs, as NCCIH wrote it. Then two of the three points under "More To Consider".
Where Bifidobacterium lactis HN019 comes from
NIH ODS notes: "Some types of fermented foods, such as yogurt, are potential sources of beneficial microbes, though not all fermented foods that contain live cultures have probiotic microorganisms." It adds: "Probiotic microorganisms are also sometimes added to unfermented foods."
A review by IFF staff states that HN019 was first isolated from commercial yogurt. The review lists dietary supplements, fermented and unfermented foods, and drinks as its uses. It adds that the strain's complete genome sequence was published in 2018. By the review's account, the subspecies is documented in human food since 1980 and was probably eaten earlier.
Terms and sources
A review by IFF staff
Cheng et al., Frontiers in Nutrition, 2021. All three authors worked for IFF, which, the review states, manufactures and markets HN019.
Several trials added HN019 to reconstituted or fermented milk.
Terms and sources
reconstituted or fermented milk
Cheng et al., 2021, Table 1.
Daily amounts and the upper limit
NIH ODS notes: "There are currently no formal recommendations for or against the use of probiotics in healthy people." It adds: "However, some expert bodies of health professionals provide guidance on the use of specific probiotic strains in people with certain health conditions." "These groups also offer guidance for clinicians and consumers on choosing probiotic products."
Terms and sources
NIH ODS notes
The first paragraph of the NIH ODS section "Probiotic Selection and Use".
In trials listed by an IFF staff review, daily amounts of HN019 ranged from 10 million to 300 billion CFU.
Terms and sources
10 million to 300 billion CFU
Cheng et al., 2021, Table 1: trials published until December 2020, including blends, infants and people with a diagnosis.
United States
There is no US recommended daily amount for HN019. The National Academies have not set an upper limit for HN019.
NCCIH notes: "Government regulation of probiotics in the United States is complex." It adds: "Depending on a probiotic product’s intended use, the FDA might regulate it as a dietary supplement, a food ingredient, or a drug." FDA had no questions about a GRAS notice for HN019 and three other B. lactis strains in foods.
Terms and sources
a GRAS notice
GRN 445, Danisco USA; FDA letter of April 2013.
We counted 298 US labels that name HN019. On 295 of them, HN019 is one of several ingredients, most often inside a blend. 3 labels list HN019 as the only ingredient; they give 57.5 mg or 3 mg per serving.
Terms and sources
298 US labels
NIH Dietary Supplement Label Database, including products no longer sold. The code HN019 as a whole word in one ingredient or form entry. We counted these.
most often inside a blend
Of all 298 labels: 238 list it in a row nested under another row, such as a blend. 37 name it only in another row's list of forms. 23 give it a row of its own.
the only ingredient
One main row naming HN019 and no other ingredient. None of the 3 gives a CFU count.
280 of the 298 labels give no separate amount for HN019. 16 give milligrams, and 2 give a count: 1 billion and 1.9 billion per serving. Where a blend that holds HN019 gives its total as a count, the median is 20 billion per serving.
Terms and sources
no separate amount
243 labels list HN019 in a row of its own without an amount. 37 name it only inside another row.
a count
One in CFU and one in units. A serving is not always a full day's amount.
the median is 20 billion
11 labels, in CFU, organisms or viable cells. The count is for all strains in the blend together.
The name used most often is Bifidobacterium lactis HN019, on 100 labels. 56 labels name HN019 and the brand HOWARU in the same ingredient row. Statements on 61 labels call HN019 a trademark of Fonterra; 15 of them add that it is licensed to DuPont.
Terms and sources
used most often
Counted by exact spelling, ignoring capitals. Next come Bifidobacterium animalis lactis HN019 on 53 labels and HOWARU Bifidobacterium animalis lactis HN019 on 29. 26 more labels write Bifidobacterium lactis (HN019). We checked the 30 most common names by eye.
the brand HOWARU
In 37 of them, in the same name. 4 name the row HOWARU Bifido.
Statements on 61 labels
Label statements in the same database. One example: "HN019 is a trademark of the Fonterra Group of companies used under license." We counted these.
Forms of Bifidobacterium lactis HN019 and how they differ
NIH ODS notes: "Dietary supplements that contain probiotics can include from one to many strains." It adds: "The number of viable cells in a probiotic supplement is indicated by the number of colony-forming units (CFU) listed on the label." "However, it can be difficult to determine which products offer verifiable health benefits due to the wide variety of probiotic strains and doses found in probiotic products and inconsistent labeling practices and recommendations for use."
Terms and sources
NIH ODS notes
The whole NIH ODS paragraph under "Dietary supplements", in three sentences.
In one 8-week trial, each daily sachet held 7.0 billion CFU of HN019 at the first participant's visit. At the last participant's visit, it held 4.69 billion. In a 2-week trial, refrigerated HN019 capsules showed no significant fall in live cells. We do not rank forms.
Terms and sources
one 8-week trial
Cheng et al., JAMA Network Open, 2024, in adults with a diagnosis. Freeze-dried HN019 with maltodextrin in a 2-g sachet. Danisco China paid for the trial. Its results are not listed here.
a 2-week trial
Waller et al., Scandinavian Journal of Gastroenterology, 2011. Fonterra Research Centre paid for this trial. Its results are not listed here.
Bifidobacterium lactis HN019 in milk, capsules, sachets, lozenges and blends, and other B. lactis strains
Form
Amount of HN019
What is known
Milk with added HN019
As given in each trial
Reconstituted or fermented milk in several trials (Cheng 2021).
Capsules, sachets or lozenges with HN019
As stated on the label
Formats used in HN019 trials (Cheng 2021).
HN019 in a blend with other strains or fiber
As stated on the label
Trials of blends are not listed on this page.
Other B. animalis subsp. lactis strains, such as BB-12 and DN-173 010
No HN019
Different strains of the same subspecies (Cheng 2021).
CFU: colony-forming units, the count of live cells on a label (NIH ODS). Sources: Cheng 2021.